Danaher Corporation (LON:0R2B)
206.02
+3.15 (1.55%)
At close: Aug 29, 2025
Danaher Revenue
Danaher had revenue of $5.94B USD in the quarter ending June 27, 2025, with 3.36% growth. This brings the company's revenue in the last twelve months to $24.01B, up 1.89% year-over-year. In the year 2024, Danaher had annual revenue of $23.88B, down -0.06%.
Revenue (ttm)
$24.01B
Revenue Growth
+1.89%
P/S Ratio
6.23
Revenue / Employee
$381.16K
Employees
63,000
Market Cap
109.10B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Oxford Nanopore Technologies | 183.19M |
Danaher News
- 1 day ago - mRNA Biotechs - Long-Term Value Risks Abound - Seeking Alpha
- 2 days ago - How Do Investors Really Feel About Danaher? - Benzinga
- 7 days ago - $1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Benzinga
- 16 days ago - iA Global Buys the Dip in Danaher's Stock Price - The Motley Fool
- 17 days ago - EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR - Business Wire
- 22 days ago - Analysts' Top S&P 500 Stocks to Buy Now - Kiplinger
- 25 days ago - Danaher Stock Closes Near Day's High After Key Trading Signal - Benzinga
- 25 days ago - Danaher Stock Closes Near Day's High After Key Trading Signal - Benzinga